Active Hexose Correlated Compound (AHCC) is a hybrid extract of several species of mycelia mushrooms and has been cultivated by the Japanese since the mid-1980s. It has been extensively researched as a specialty immune supplement and is Japan's leading alternative cancer therapy supplement used in hundred of cancer clinics throughout Asia.

[Read More] [Read Less]

AHCC is a daily immune supplement for those seeking to help the body fight abnormal cell growth, which can lead to tumours, cancer, chronic disease and infections. It has been studied and used successfully to treat everything from minor ailments (cough and flu) to serious diseases (cancer, diabetes, hepatitis, cardiovascular disease).

Natural Killer (NK) cells are white blood cells that destroy infected or abnormal cells by injecting granules into them which cause them to explode. AHCC greatly increases NK cell activity by 300-800%. Research data from over 100,000 cancer patients noted that AHCC treatment to be of benefit 60% of the time. AHCC is particular effective for liver, lung, stomach, colon, breast, thyroid, ovarian, testicular, tongue, kidney and pancreatic cancers.

A landmark study involving 269 patients with liver cancer following surgery were dramatic: At the end of ten years, 34.5% of AHCC patients' cancer recurred, compared with 66.1% of the control group. 46.8% of the patients in the control group had died within ten years, less than half the amount of the AHCC group. The AHCC group also displayed a better quality of life, physical health and performed regular daily activities.